Back to companies
Ultragenyx Pharmaceutical Inc.
RAREUSNASDAQPharmaceuticals & HealthcareUltragenyx Pharmaceutical Inc.
Revenue
$673.0mn
YoY +20.1%
Operating income
-$535.0mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API